Trials / Completed
CompletedNCT00559689
Study of Inhaled Glucocorticosteroid Administration in Asthma Patients
Phase 4 Study of Once-Daily Inhaled Glucocorticosteroid Administration in Asthma Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 24 (actual)
- Sponsor
- Hamamatsu University · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Once-daily inhaled glucocorticosteroids treatment can sufficiently control airway inflammation in asthma patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Budesonide,hydrofluoroalkane-beclomethasone dipropionate | receive twice-daily administration |
| DRUG | Budesonide,hydrofluoroalkane-beclomethasone | once-daily administration at bedtime |
Timeline
- Start date
- 2005-11-01
- Completion
- 2007-03-01
- First posted
- 2007-11-16
- Last updated
- 2009-03-16
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00559689. Inclusion in this directory is not an endorsement.